TrialThis is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza
Trial details
- Registry ID
- NCT07371650
- Phase
- Phase 2
Drug research
TRX-100
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate InfluenzaNCT07371650 | TRAW | Phase 2 | Active not recruiting | 2026-12Estimated |
| Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge ModelNCT07503405 | TRAW | Phase 2 | Not yet recruiting | 2026-11Estimated |
Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model
Trial details
- Registry ID
- NCT07503405
- Phase
- Phase 2
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |